See more : Circle Entertainment Inc. (CEXE) Income Statement Analysis – Financial Results
Complete financial analysis of Yabao Pharmaceutical Group Co., Ltd (600351.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yabao Pharmaceutical Group Co., Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Macondray Capital Acquisition Corp. I (DRAYU) Income Statement Analysis – Financial Results
- Shukra Bullions Limited (SKRABUL.BO) Income Statement Analysis – Financial Results
- PacWest Bancorp (PACW) Income Statement Analysis – Financial Results
- Gujarat Ambuja Exports Limited (GAEL.BO) Income Statement Analysis – Financial Results
- TGS Esports Inc. (TGSEF) Income Statement Analysis – Financial Results
Yabao Pharmaceutical Group Co., Ltd (600351.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.yabao.com.cn
About Yabao Pharmaceutical Group Co., Ltd
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao brands. It also offers plastic bottles and cartons. The company provides its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.91B | 2.72B | 2.76B | 2.60B | 3.04B | 2.92B | 2.56B | 1.81B | 2.07B | 1.89B | 1.62B | 1.27B | 1.66B | 1.18B | 1.49B | 1.25B | 986.05M | 741.30M | 685.78M | 596.80M | 373.49M | 212.63M | 154.55M | 133.60M | 125.56M |
| Cost of Revenue | 1.25B | 1.20B | 1.08B | 1.06B | 1.11B | 1.16B | 1.12B | 1.01B | 979.65M | 896.75M | 885.63M | 617.27M | 909.64M | 634.96M | 969.28M | 839.95M | 645.39M | 477.93M | 443.79M | 385.27M | 203.02M | 96.60M | 74.89M | 62.67M | 70.36M |
| Gross Profit | 1.66B | 1.52B | 1.69B | 1.54B | 1.93B | 1.75B | 1.44B | 796.44M | 1.09B | 992.91M | 739.25M | 649.30M | 753.11M | 546.86M | 518.99M | 414.70M | 340.66M | 263.37M | 242.00M | 211.54M | 170.47M | 116.03M | 79.67M | 70.93M | 55.20M |
| Gross Profit Ratio | 57.19% | 55.88% | 61.03% | 59.32% | 63.57% | 60.09% | 56.39% | 44.10% | 52.57% | 52.54% | 45.50% | 51.26% | 45.29% | 46.27% | 34.87% | 33.05% | 34.55% | 35.53% | 35.29% | 35.44% | 45.64% | 54.57% | 51.55% | 53.09% | 43.96% |
| Research & Development | 106.08M | 130.62M | 157.13M | 144.46M | 112.79M | 112.13M | 140.70M | 84.49M | 54.52M | 56.09M | 23.48M | 32.85M | 18.55M | 8.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 57.47M | 53.40M | 57.16M | 57.77M | 67.68M | 66.83M | 64.02M | 79.92M | 64.90M | 61.77M | 62.86M | 56.17M | 53.91M | 51.26M | 124.40M | 113.24M | 76.30M | 76.73M | 73.41M | 56.54M | 48.20M | 31.47M | 19.13M | 20.44M | 21.67M |
| Selling & Marketing | 971.69M | 897.47M | 1.04B | 980.72M | 1.14B | 962.26M | 694.22M | 438.43M | 452.49M | 426.36M | 341.28M | 282.45M | 214.51M | 205.59M | 207.56M | 160.57M | 169.57M | 133.04M | 107.53M | 88.51M | 71.65M | 41.12M | 24.97M | 22.12M | 16.74M |
| SG&A | 1.03B | 950.87M | 1.10B | 1.04B | 1.21B | 1.03B | 758.24M | 518.35M | 517.39M | 488.13M | 404.14M | 338.62M | 268.42M | 256.84M | 331.97M | 273.81M | 245.88M | 209.77M | 180.94M | 145.05M | 119.85M | 72.60M | 44.09M | 42.56M | 38.41M |
| Other Expenses | 302.63M | 222.74M | 205.18M | 198.84M | 220.42M | -898.57K | -3.75M | 89.57M | 24.89M | 11.24M | 46.00M | 38.68M | 25.11M | 5.94M | 3.46M | 5.46M | 618.86K | -535.52K | 1.49M | -205.07K | 608.97K | -421.02K | 6.36M | 4.33M | -44.56K |
| Operating Expenses | 1.44B | 1.30B | 1.46B | 1.38B | 1.54B | 1.38B | 1.16B | 826.74M | 822.03M | 763.11M | 603.23M | 505.65M | 460.92M | 363.60M | 341.00M | 281.78M | 253.13M | 215.01M | 185.60M | 148.90M | 122.87M | 74.94M | 45.45M | 43.84M | 39.61M |
| Cost & Expenses | 2.68B | 2.50B | 2.54B | 2.44B | 2.65B | 2.54B | 2.27B | 1.84B | 1.80B | 1.66B | 1.49B | 1.12B | 1.37B | 998.56M | 1.31B | 1.12B | 898.52M | 692.94M | 629.39M | 534.17M | 325.90M | 171.54M | 120.34M | 106.51M | 109.97M |
| Interest Income | 9.49M | 8.18M | 8.50M | 3.63M | 2.88M | 1.44M | 5.16M | 5.34M | 2.72M | 3.37M | 2.85M | 5.25M | 3.86M | 4.72M | 5.04M | 2.82M | 3.23M | 3.08M | 4.77M | 3.80M | 2.59M | 333.24K | 132.85K | 223.58K | -0.16 |
| Interest Expense | 12.30M | 18.77M | 22.61M | 32.61M | 48.04M | 34.83M | 42.46M | 34.27M | 52.80M | 50.26M | 48.33M | 52.20M | 45.87M | 32.44M | 29.82M | 27.44M | 23.17M | 25.96M | 31.79M | 21.84M | 12.42M | 10.48M | 6.52M | 4.09M | 5.67M |
| Depreciation & Amortization | 159.20M | 164.38M | 172.24M | 170.81M | 174.34M | 173.36M | 174.70M | 158.37M | 135.40M | 125.80M | 92.91M | 89.54M | 73.66M | 51.31M | 44.90M | 42.42M | 39.54M | 33.24M | 25.15M | 15.04M | 11.38M | 6.42M | 5.38M | 4.43M | 5.71M |
| EBITDA | 391.76M | 309.68M | 398.74M | 338.40M | 284.16M | 515.58M | 441.91M | 220.73M | 397.17M | 366.12M | 271.90M | 271.42M | 360.93M | 246.55M | 230.47M | 181.72M | 130.64M | 82.76M | 87.24M | 80.72M | 62.04M | 47.38M | 39.36M | 27.74M | 15.60M |
| EBITDA Ratio | 13.46% | 14.14% | 15.06% | 12.98% | 18.12% | 18.89% | 18.00% | 12.28% | 21.27% | 19.69% | 17.57% | 21.86% | 23.60% | 21.10% | 15.50% | 14.60% | 13.20% | 11.16% | 12.72% | 13.53% | 16.64% | 22.28% | 25.46% | 20.76% | 12.42% |
| Operating Income | 226.34M | 220.40M | 203.22M | 127.35M | 378.52M | 330.86M | 228.43M | -60.42M | 224.15M | 183.61M | 90.63M | 91.14M | 229.09M | 159.63M | 152.99M | 106.06M | 66.85M | 25.10M | 30.10M | 44.78M | 38.74M | 31.34M | 27.95M | 23.30M | 9.89M |
| Operating Income Ratio | 7.78% | 8.11% | 7.35% | 4.89% | 12.44% | 11.34% | 8.93% | -3.35% | 10.85% | 9.72% | 5.58% | 7.20% | 13.78% | 13.51% | 10.28% | 8.45% | 6.78% | 3.39% | 4.39% | 7.50% | 10.37% | 14.74% | 18.08% | 17.44% | 7.88% |
| Total Other Income/Expenses | -7.35M | 2.10M | -1.62M | 70.63K | 3.87M | -898.57K | -3.75M | 31.04M | 23.67M | 6.45M | 39.51M | 37.89M | -46.14M | -18.61M | -21.86M | -21.50M | -20.07M | -26.93M | -27.39M | -19.52M | -498.64K | -869.24K | -493.96K | 339.92K | -11.55K |
| Income Before Tax | 218.98M | 125.65M | 201.59M | 127.42M | 49.88M | 329.97M | 224.68M | 27.82M | 247.82M | 190.06M | 130.14M | 129.02M | 241.40M | 162.74M | 155.68M | 111.42M | 67.47M | 23.56M | 30.30M | 43.85M | 38.33M | 30.47M | 27.46M | 23.64M | 9.88M |
| Income Before Tax Ratio | 7.53% | 4.62% | 7.29% | 4.90% | 1.64% | 11.31% | 8.78% | 1.54% | 12.00% | 10.06% | 8.01% | 10.19% | 14.52% | 13.77% | 10.46% | 8.88% | 6.84% | 3.18% | 4.42% | 7.35% | 10.26% | 14.33% | 17.76% | 17.70% | 7.87% |
| Income Tax Expense | 39.07M | 21.04M | 17.83M | 18.43M | 39.08M | 45.95M | 24.86M | 777.76K | 29.78M | 24.95M | 16.88M | 19.16M | 43.99M | 23.35M | 27.52M | 24.66M | 19.51M | 9.38M | 13.42M | 15.72M | 13.65M | 10.53M | 9.20M | 8.33M | 3.35M |
| Net Income | 199.59M | 104.66M | 187.09M | 107.37M | 10.80M | 273.34M | 200.21M | 22.52M | 222.09M | 170.12M | 118.20M | 112.29M | 186.43M | 144.30M | 129.29M | 85.46M | 45.06M | 21.82M | 24.36M | 31.25M | 24.97M | 19.46M | 17.97M | 14.53M | 6.79M |
| Net Income Ratio | 6.86% | 3.85% | 6.77% | 4.13% | 0.35% | 9.37% | 7.83% | 1.25% | 10.75% | 9.00% | 7.27% | 8.87% | 11.21% | 12.21% | 8.69% | 6.81% | 4.57% | 2.94% | 3.55% | 5.24% | 6.69% | 9.15% | 11.62% | 10.87% | 5.41% |
| EPS | 0.26 | 0.14 | 0.24 | 0.14 | 0.01 | 0.35 | 0.25 | 0.03 | 0.32 | 0.25 | 0.17 | 0.17 | 0.29 | 0.23 | 0.20 | 0.29 | 0.10 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 |
| EPS Diluted | 0.26 | 0.14 | 0.24 | 0.14 | 0.01 | 0.35 | 0.25 | 0.03 | 0.32 | 0.25 | 0.17 | 0.17 | 0.29 | 0.23 | 0.20 | 0.29 | 0.10 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 |
| Weighted Avg Shares Out | 767.64M | 770.00M | 770.00M | 770.00M | 770.00M | 784.77M | 786.97M | 787.04M | 692.00M | 680.49M | 695.27M | 660.51M | 642.86M | 627.40M | 646.96M | 294.68M | 537.48M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M |
| Weighted Avg Shares Out (Dil) | 763.23M | 770.00M | 770.00M | 770.00M | 770.00M | 784.77M | 786.97M | 787.48M | 692.09M | 680.49M | 695.27M | 660.51M | 642.86M | 627.40M | 646.96M | 294.68M | 537.48M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M | 552.94M |
No news found for: 600351.SS
Source: https://incomestatements.info
Category: Stock Reports